Skip to main content
. 2011 Sep 26;17(Suppl 6):E1–E59. doi: 10.1111/j.1469-0691.2011.03672.x
Reference Objective Design Evidence
Poole et al. [493] Mucolytics for CB or COPD MA 1A+